IS8001A - Bíarýl setin tríasól sem natríum ganga tálmar - Google Patents

Bíarýl setin tríasól sem natríum ganga tálmar

Info

Publication number
IS8001A
IS8001A IS8001A IS8001A IS8001A IS 8001 A IS8001 A IS 8001A IS 8001 A IS8001 A IS 8001A IS 8001 A IS8001 A IS 8001A IS 8001 A IS8001 A IS 8001A
Authority
IS
Iceland
Prior art keywords
baryl
substituted triazole
sodium inhibits
inhibits
sodium
Prior art date
Application number
IS8001A
Other languages
English (en)
Inventor
K. Chakravarty Prasun
H. Fisher Michael
Palucki Brenda
K. Park Min
H. Parsons William
Zhou Bishan
P. Carey James
E. Frantz Douglas
H. Kress Michael
Weaver Damian
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Publication of IS8001A publication Critical patent/IS8001A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS8001A 2003-03-18 2005-08-29 Bíarýl setin tríasól sem natríum ganga tálmar IS8001A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45595203P 2003-03-18 2003-03-18
PCT/US2004/007830 WO2004083190A1 (en) 2003-03-18 2004-03-12 Biaryl substituted triazoles as sodium channel blockers

Publications (1)

Publication Number Publication Date
IS8001A true IS8001A (is) 2005-08-29

Family

ID=33030073

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8001A IS8001A (is) 2003-03-18 2005-08-29 Bíarýl setin tríasól sem natríum ganga tálmar

Country Status (34)

Country Link
US (2) US7326726B2 (is)
EP (1) EP1606269B1 (is)
JP (1) JP4482554B2 (is)
KR (1) KR100737721B1 (is)
CN (2) CN1788002A (is)
AR (1) AR044503A1 (is)
AT (1) ATE412639T1 (is)
AU (1) AU2004221885C1 (is)
BR (1) BRPI0408407A (is)
CA (1) CA2519252C (is)
CL (1) CL2004000551A1 (is)
CY (1) CY1108720T1 (is)
DE (1) DE602004017438D1 (is)
DK (1) DK1606269T3 (is)
EC (1) ECSP056018A (is)
EG (1) EG25994A (is)
ES (1) ES2314387T3 (is)
HR (1) HRP20050816A2 (is)
IS (1) IS8001A (is)
JO (1) JO2480B1 (is)
MA (1) MA27665A1 (is)
MX (1) MXPA05009847A (is)
MY (1) MY142651A (is)
NO (1) NO20054775L (is)
NZ (1) NZ542205A (is)
PE (1) PE20041066A1 (is)
PL (1) PL1606269T3 (is)
PT (1) PT1606269E (is)
RU (1) RU2356897C2 (is)
SI (1) SI1606269T1 (is)
TW (1) TWI337605B (is)
UA (1) UA81660C2 (is)
WO (2) WO2004083189A1 (is)
ZA (1) ZA200506906B (is)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2510455C (en) 2002-12-19 2013-03-12 The Scripps Research Institute Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
MY142651A (en) * 2003-03-18 2010-12-15 Merck Sharp & Dohme Biaryl substituted triazoles as sodium channel blockers
US20090074890A1 (en) * 2003-11-10 2009-03-19 Park Min K Substituted Triazoles as Sodium Channel Blockers
WO2005118511A2 (en) 2004-05-20 2005-12-15 The Scripps Research Institute Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
TW200728258A (en) 2005-10-10 2007-08-01 Glaxo Group Ltd Novel compounds
TW200730494A (en) 2005-10-10 2007-08-16 Glaxo Group Ltd Novel compounds
JP5139307B2 (ja) 2005-10-10 2013-02-06 グラクソ グループ リミテッド ナトリウムチャネルモジュレーターとしてのプロリンアミド誘導体
EP2117538A1 (en) * 2007-01-24 2009-11-18 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)
CN101679319B (zh) 2007-02-08 2014-07-09 辛塔医药品有限公司 用于治疗增生性病症如癌症的三唑类化合物
ES2601856T3 (es) 2007-06-08 2017-02-16 Mannkind Corporation Inhibidores de la IRE-1A
DK2464645T3 (en) 2009-07-27 2017-10-23 Gilead Sciences Inc CONDENSED, HETEROCYCLIC COMPOUNDS AS IRON CHANNEL MODULATORS
MX2012015096A (es) 2010-07-02 2013-05-28 Gilead Sciences Inc Compuestos heterociclicos fusionados como moduladores del canal ion.
AU2012253653A1 (en) 2011-05-10 2013-05-02 Gilead Sciences, Inc. Fused heterocyclic compounds as sodium channel modulators
UY34171A (es) 2011-07-01 2013-01-31 Gilead Sciences Inc Compuestos heterocíclicos fusionados como moduladores del canal iónico
NO3175985T3 (is) 2011-07-01 2018-04-28
EP2755961A1 (en) 2011-09-16 2014-07-23 Pfizer Inc Solid forms of a transthyretin dissociation inhibitor
WO2013131018A1 (en) * 2012-03-02 2013-09-06 Zalicus Pharmaceuticals Ltd. Biaryl inhibitors of the sodium channel
TWI568722B (zh) 2012-06-15 2017-02-01 葛蘭馬克製藥公司 作爲ｍＰＧＥＳ－１抑制劑之三唑酮化合物
EP2967073B9 (en) 2013-03-15 2019-04-10 Bristol-Myers Squibb Company Lxr modulators
EP3237379B1 (en) 2014-12-23 2022-04-06 Convergence Pharmaceuticals Limited Process for preparing alpha-carboxamide pyrrolidine derivatives
JP6616244B2 (ja) * 2015-05-29 2019-12-04 北興化学工業株式会社 新規なヒドロキシフェニルボロン酸エステルとその製造方法、およびヒドロキシビフェニル化合物の製造法
WO2019071162A2 (en) 2017-10-05 2019-04-11 Biogen Inc. PROCESS FOR THE PREPARATION OF PYRROLIDINE ALPHA-CARBOXAMIDE DERIVATIVES
KR102512548B1 (ko) 2017-12-22 2023-03-22 삼성디스플레이 주식회사 유기 전계 발광 소자 및 유기 전계 발광 소자용 함질소 화합물
EP3762367A1 (en) * 2018-03-09 2021-01-13 PI Industries Ltd. Heterocyclic compounds as fungicides
CN108863965A (zh) * 2018-06-25 2018-11-23 青岛科技大学 一锅法制备1,2,4-三氮唑-3-甲酰胺的方法
CN108794413A (zh) * 2018-06-25 2018-11-13 青岛科技大学 一种1,2,4-三氮唑-3-甲酰胺的合成方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US875782A (en) * 1907-04-29 1908-01-07 Walter H Cook Fast-nut.
TW226993B (is) * 1992-05-29 1994-07-21 Kumiai Chemical Industry Co
US5455252A (en) * 1993-03-31 1995-10-03 Syntex (U.S.A.) Inc. Optionally substituted 6,8-quinolines
IT1292091B1 (it) * 1997-06-05 1999-01-25 Geange Ltd Derivati eterociclici aromatici azotati,procedimento per la loro preparazione e loro impiego come antigestativi,immunosoppressori e
GB9726987D0 (en) 1997-12-22 1998-02-18 Glaxo Group Ltd Compounds
AU782353B2 (en) * 1999-03-26 2005-07-21 Euro-Celtique S.A. Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
AR029489A1 (es) 2000-03-10 2003-07-02 Euro Celtique Sa Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento
US6962936B2 (en) * 2001-04-27 2005-11-08 Vertex Pharmaceuticals Incorporated Triazole-derived kinase inhibitors and uses thereof
US6797722B2 (en) * 2002-05-03 2004-09-28 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole for the treatment of autoimmune diseases
CN1665500A (zh) * 2002-07-09 2005-09-07 百时美施贵宝公司 用作抗糖尿病和抗肥胖症试剂的取代杂环衍生物及方法
KR100467668B1 (ko) * 2002-08-07 2005-01-24 씨제이 주식회사 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
KR100470075B1 (ko) * 2002-11-21 2005-02-05 씨제이 주식회사 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
JO2397B1 (en) * 2002-12-20 2007-06-17 ميرك شارب اند دوم كوربوريشن Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors
MY142651A (en) * 2003-03-18 2010-12-15 Merck Sharp & Dohme Biaryl substituted triazoles as sodium channel blockers
US20090074890A1 (en) * 2003-11-10 2009-03-19 Park Min K Substituted Triazoles as Sodium Channel Blockers

Also Published As

Publication number Publication date
US7572822B2 (en) 2009-08-11
MA27665A1 (fr) 2005-12-01
ZA200506906B (en) 2007-02-28
UA81660C2 (ru) 2008-01-25
ECSP056018A (es) 2006-01-27
HRP20050816A2 (hr) 2006-04-30
US20080171777A1 (en) 2008-07-17
NO20054775L (no) 2005-12-16
BRPI0408407A (pt) 2006-03-21
JO2480B1 (en) 2009-01-20
CL2004000551A1 (es) 2005-01-21
CY1108720T1 (el) 2013-09-04
CA2519252C (en) 2008-11-18
TWI337605B (en) 2011-02-21
MY142651A (en) 2010-12-15
AU2004221885A1 (en) 2004-09-30
TW200505876A (en) 2005-02-16
DE602004017438D1 (de) 2008-12-11
JP2006520782A (ja) 2006-09-14
PE20041066A1 (es) 2005-01-22
US20050119261A1 (en) 2005-06-02
ATE412639T1 (de) 2008-11-15
SI1606269T1 (sl) 2009-02-28
JP4482554B2 (ja) 2010-06-16
NO20054775D0 (no) 2005-10-17
NZ542205A (en) 2008-11-28
US7326726B2 (en) 2008-02-05
PT1606269E (pt) 2008-12-16
AU2004221885B2 (en) 2010-04-22
CN1788002A (zh) 2006-06-14
KR100737721B1 (ko) 2007-07-11
EP1606269A1 (en) 2005-12-21
RU2356897C2 (ru) 2009-05-27
RU2005132168A (ru) 2006-04-27
PL1606269T3 (pl) 2009-04-30
AU2004221885C1 (en) 2010-09-23
WO2004083189A1 (en) 2004-09-30
ES2314387T3 (es) 2009-03-16
CN101289428A (zh) 2008-10-22
DK1606269T3 (da) 2009-02-09
CA2519252A1 (en) 2004-09-30
MXPA05009847A (es) 2005-12-05
EP1606269B1 (en) 2008-10-29
KR20050109583A (ko) 2005-11-21
EG25994A (en) 2012-11-28
AR044503A1 (es) 2005-09-14
WO2004083190A1 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
IS8001A (is) Bíarýl setin tríasól sem natríum ganga tálmar
IS8238A (is) Pýrrólótvíhýdróísókínólín sem PDE10 tálmar
IS8345A (is) 6-útskipt anilínópúrín sem RTK-tálmar
IS7884A (is) Díasepínóindól afleiður sem kínasa hindrar
IS8384A (is) Alkýleraðar bensímídasólafleiður sem MEK-hindrar
IS7717A (is) Pýrídasínónafleiður sem PDF4-hemlar
IL176451A0 (en) Novel 2-heteroaryl-substituted benzimidazole derivative
IS8492A (is) Setin arýlpýrasól sem snýkladeyðandi miðlar
IS7660A (is) Nýjar bensóímídasólafleiður nytsamlegar sem andviðkomumiðlar
DK1569937T3 (da) C-6 modificerede indazolylpyrrolotriaziner
IS8006A (is) Setin pýrimidínón
IL199668A0 (en) New benzimidazole derivatives
DK1841758T3 (da) Substituerede triazol-derivater som oxytocin-antagonister
IS8117A (is) 3-Flúr-píperidín sem NMDA/NR2B mótlyf
IS7509A (is) Þíoxantínafleiður sem mergperoxídasatálmar
IS7795A (is) Pyrrólafleiður sem efnasambönd gegn sveppagerlum
DE60333528D1 (de) Elektrolytzusammensetzungen
DE60320902D1 (de) Zusammensetzungen mit ausgelöster Freisetzung
IS2450B (is) Tríasól efnasambönd sem eru gagnleg við meðferð
DK1492934T3 (da) Dørenhed
DE60325848D1 (de) Flammwidrige zusammensetzungen
FI20020313A (fi) Uudet tärkkelyskoostumukset
SE0302278L (sv) Skyddsvall
DE602004002778D1 (de) Bleichmittelzusammensetzungen
ATE365529T1 (de) Schweisshemmende zusammensetzungen